ArticleClinical lung cancer2026

Real-World Effectiveness of Second-Line Therapies in Advanced Non-Small Cell Lung Cancer: Insights From Propensity-Weighted Comparative Analyses of Longitudinal EHR Data.

Gary C N Hettinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.